Taken together, gossypetin may serve as a novel compound in the treatment of cognition impairments in T2DM due to its ability to reduce oxidative stress and inflammation, decrease cortisol levels and increase BDNF levels. This evidence concerns the gene BDNF and Cognitive impairment.